SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 8.75 |
| Enterprise Value ($M) | 50.79 |
| Book Value ($M) | -106.63 |
| Book Value / Share | -24.29 |
| Price / Book | -0.10 |
| NCAV ($M) | -98.38 |
| NCAV / Share | -26.75 |
| Price / NCAV | -0.09 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -2.50 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.20 |
| Current Ratio | 0.20 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 6.05 |
| Assets | 14.51 |
| Liabilities | 121.13 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Highbridge Capital Management Llc | 9.99 | ||
| 13D/A | Athyrium Opportunities III Co-Invest 1 LP | 49.90 | 1.21 | |
| 13G | Davidson Kempner Capital Management Lp | 9.90 | ||
| 13D/A | Athyrium Opportunities 2020 LP | 49.90 | 19.07 | |
| 13G/A | Armistice Capital, Llc | 3.80 | -91.72 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 50,753 | 187,079 | 27.13 | |
| 35,240 | 84,953 | 41.48 | |
| 17,299 | 127,176 | 13.60 | |
| 22,568 | 111,835 | 20.18 | |
| 48,561 | 205,815 | 23.59 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AXSM – Axsome Therapeutics, Inc. | BCAB – BioAtla, Inc. |
| BHST – BioHarvest Sciences Inc. | BTMD – biote Corp. |
| CADL – Candel Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io